Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI

Diabetologia

Volumn 46, Issue 12, 2003, Pages 1604-1610

  Den Heijer, T ^a   Vermeer, S E ^a   Van Dijk, E J ^a   Prins, N D ^a   Koudstaal, P J ^a   Hofman, A ^a   Breteler, M M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Amygdala; Brain; Dementia; Epidemiology; Glucose; Hippocampus; Insulin; Memory; MRI; Type 2 diabetes

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; ATHEROSCLEROSIS; BRAIN ATROPHY; BRAIN INJURY; BRAIN SIZE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; TEMPORAL LOBE; WHITE MATTER;

AGED; ATROPHY; CAROTID STENOSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; TEMPORAL LOBE;

EID: 0346216156     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1235-0     Document Type: Article

References (51)

1. Goldstein LB, Adams R, Becker K et al. (2001) Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 103:163-182
2. Hébert R, Lindsay J, Verreault R et al. (2000) Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke 31:1487-1493
3. Ott A, Stolk RP, van Harskamp F et al. (1999) Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53:1937-1942
4. Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 51:1256-1262
5. Snowdon DA, Greiner LH, Mortimer JA et al. (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277:813-817
6. Vitek MP, Bhattacharya K, Glendening JM et al. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91:4766-4770
7. Gasparini L, Netzer WJ, Greengard P et al. (2002) Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol Sci 23:288-293
8. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
9. Gosche KM, Mortimer JA, Smith CD et al. (2002) Hippocampal volume as an index of Alzheimer neuropathology. findings from the Nun Study. Neurology 58:1476-1482
10. Convit A, De Leon MJ, Tarshish C et al. (1997) Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging 18:131-138
11. Jack CR Jr, Petersen RC, Xu YC et al. (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52:1397-1403
12. Schott JM, Fox NC, Frost C et al. (2003) Assessing the onset of structural change in familial Alzheimer's disease. Ann Neurol 53:181-188
13. Callen DJ, Black SE, Gao F et al. (2001) Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 57:1669-1674
14. Krasuski JS, Alexander GE, Horwitz B et al. (1998) Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol Psychiatry 43:60-68
15. Hofman A, Grobbee DE, de Jong PTVM et al. (1991) Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7:403-422
16. Breteler MMB (2000) Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann NY Acad Sci 903:457-465
17. Ott A, Stolk RP, Hofman A et al. (1996) Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39:1392-1397
18. de Leeuw FE, de Groot JC, Oudkerk M et al. (1999) A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol 46:827-833
19. de Groot JC, de Leeuw FE, Oudkerk M et al. (2000) Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 47:145-151
20. Hackert VH, den Heijer T, Oudkerk M et al. (2002) Hippocampal head size associated with verbal memory performance in nondemented elderly. Neuroimage 17:1365-1372
21. Maunoury C, Michot JL, Caillet H et al. (1996) Specificity of temporal amygdala atrophy in Alzheimer's disease: quantitative assessment with magnetic resonance imaging. Dementia 7:10-14
22. UNESCO: International Standard Classification of Education (ISCED). Document 19C/3. Paris, 1976
23. Vermeer SE, den Heijer T, Koudstaal PJ et al. (2003) Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 34:392-396
24. Slooter AJC, Cruts M, Kalmijn S et al. (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 55:964-968
25. Farrer LA, Cupples LA, Haines JL et al. (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349-1356
26. Bots ML, Hoes AW, Koudstaal PJ et al. (1997) Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96:1432-1437
27. Mooy JM, Grootenhuis PA, de Vries H et al. (1995) Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study. Diabetes Care 18:1270-1273
28. Laakso M (1993) How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965
29. Leibson CL, Rocca WA, Hanson VA et al. (1997) The risk of dementia among persons with diabetes mellitus: a population-based cohort study. Ann NY Acad Sci 826:422-427
30. Brayne C, Gill C, Huppert FA et al. (1998) Vascular risks and incident dementia: results from a cohort study of the very old. Dement Geriatr Cogn Disord 9:175-180
31. Yoshitake T, Kiyohara Y, Kato I et al. (1995) Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 45:1161-1168
32. Luchsinger JA, Tang MX, Stern Y et al. (2001) Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154:635-641
33. MacKnight C, Rockwood K, Awalt E et al. (2002) Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 14:77-83
34. Curb JD, Rodriguez BL, Abbott RD et al. (1999) Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology 52:971-975
35. Tariot PN, Ogden MA, Cox C et al. (1999) Diabetes and dementia in long-term care. J Am Geriatr Soc 47:423-429
36. Bobinski M, de Leon MJ, Wegiel J et al. (2000) The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience 95:721-725
37. Petersen RC, Smith GE, Ivnik RJ et al. (1994) Memory function in very early Alzheimer's disease. Neurology 44: 867-872
38. Petersen RC, Jack CR Jr, Xu YC et al. (2000) Memory and MRI-based hippocampal volumes in aging and AD. Neurology 54:581-587
39. Convit A, Wolf OT, Tarshish C et al. (2003) Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci USA 100:2019-2022
40. Heitner J, Dickson D (1997) Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 49:1306-1311
41. Münch G, Schinzel R, Loske C et al. (1998) Alzheimer's disease - synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm 105:439-461
42. Ledesma MD, Bonay P, Colaco C et al. (1994) Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 269:21614-21619
43. Kuusisto J, Koivisto K, Mykkänen L et al. (1997) Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study. BMJ 315:1045-1049
44. Craft S, Peskind E, Schwartz MW et al. (1998) Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 50:164-168
45. Frölich L, Blum-Degen D, Bernstein HG et al. (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 105:423-438
46. Liolitsa D, Powell J, Lovestone S (2002) Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 73:261-266
47. Zhao WQ, Alkon DL (2001) Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 177: 125-134
48. Kurochkin IV (2001) Insulin-degrading enzyme: embarking on amyloid destruction. Trends Biochem Sci 26:421-425
49. Farris W, Mansourian S, Chang Y et al. (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100:4162-4167
50. Frölich L, Blum-Degen D, Riederer P et al. (1999) A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann NY Acad Sci 893:290-293
51. Schulingkamp RJ, Pagano TC, Hung D et al. (2000) Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 24:855-872